Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (35) , 12485-12497
Abstract
No abstract availableKeywords
Funding Information
- Barth Syndrome Foundation (Research Grant)
- American Heart Association (Grant #0835545N)
This publication has 68 references indexed in Scilit:
- Left ventricular noncompaction (LVNC) and low mitochondrial membrane potential are specific for Barth syndromeJournal of Inherited Metabolic Disease, 2013
- Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown MiceFrontiers in Physiology, 2013
- Measurement of tissue acyl-CoAs using flow-injection tandem mass spectrometry: acyl-CoA profiles in short-chain fatty acid oxidation defectsMolecular Genetics and Metabolism, 2012
- Characterization of a Transgenic Short Hairpin RNA-Induced Murine Model of Tafazzin DeficiencyHuman Gene Therapy, 2011
- Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth SyndromeJournal of Biological Chemistry, 2011
- Measurement of Mitochondrial ROS Production2010
- Thioesterase superfamily member 2 (Them2)/acyl-CoA thioesterase 13 (Acot13): a homotetrameric hotdog fold thioesterase with selectivity for long-chain fatty acyl-CoAsBiochemical Journal, 2009
- Assigning Significance to Peptides Identified by Tandem Mass Spectrometry Using Decoy DatabasesJournal of Proteome Research, 2007
- Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomographyLaboratory Investigation, 2006
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006